Beta Bionics Inc
Beta Bionics Inc (BBNX) Historical Volatility
BBNX's 30 day historical volatility is 96.90%, in the 88th percentile of readings over the past year. This is a high percentile, meaning Beta Bionics Inc shares have swung far more than usual. BBNX's 30 day implied volatility sits at 141.68%, with an IV Rank of 63.89%, leaving IV 44.78 points above historical volatility. This means options are pricing in more movement than the stock has actually delivered, as of Nov 17, 2026.
Read more
Tracking BBNX historical volatility helps you see how much Beta Bionics Inc's stock price has actually moved, giving you a baseline for whether option premiums look fair, cheap, or expensive. While implied volatility shows what the market expects, BBNX's HV, also known as realized volatility, shows what actually happened. Use our scanner to monitor BBNX 30 day historical volatility alongside longer lookback windows and spot the moments when realized and implied diverge.
Historical volatility is the annualized standard deviation of a stock's past returns, typically measured over rolling windows like 10, 20, 30, or 60 days. BBNX's 30 day historical volatility, or BBNX HV, is one of the most widely watched readings because it balances responsiveness with stability. Comparing BBNX's HV to its implied volatility reveals the volatility risk premium. When IV sits well above HV, options are pricing in more movement than the stock has actually delivered, giving option sellers an edge. When HV runs hot relative to IV, options are pricing in less movement than the stock has delivered, and buyers may be underpaying for it.
Beta Bionics, Inc., a commercial-stage medical device company, engages in the design, development, and commercialization of solutions to enhance the health and quality of life of insulin-requiring people with diabetes. It offers iLet Bionic Pancreas, an insulin delivery device for the treatment of type 1 diabetes in adults and children six years of age and older. The company is also developing Patch Pump, an insulin pump that is designed to adhere directly to the skin and administer insulin without the need for tubing; Bihormonal iLet, which combines automated delivery of insulin and glucagon; and iLet to treat people with insulin-dependent type-2 diabetes.
Historical Volatility
Historical movement is elevated versus the past year. The stock has been unusually active.
As of Nov 17, 2026
As of Nov 17, 2026
As of Nov 17, 2026
Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →